ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Alzheimer's drug combo faces safety test
Disease control Not yet recruitingThis study aims to check if a new drug combination called X/T+X-EC is safe and tolerable for people with Alzheimer's disease who are already being treated with the medication lecanemab. It will involve 60 participants aged 60-85 over 32 weeks. Participants will be randomly assign…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2 • Sponsor: Neurology Office of South Florida • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Brain drain surgery: a bold new attack on Alzheimer's
Disease control Not yet recruitingThis study is testing whether a surgical procedure on the neck's drainage system, combined with standard care, can slow the progression of moderate-to-severe Alzheimer's disease. It will compare this surgery to standard care alone in about 376 patients across China. The main goal…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New drug trial aims to stop Alzheimer's before it starts
Prevention Not yet recruitingThis study is testing whether an investigational drug called HT-4253 can prevent Alzheimer's disease in people who carry a specific genetic risk factor (APOE4) and show early signs of brain changes. About 112 participants, aged 50-75 and without an Alzheimer's diagnosis, will rec…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Prevention
Last updated Mar 10, 2026 12:54 UTC